Skip Navigation
News and Publications
In This Section      
Print This Page

Current News Releases

Current News Releases

Released: March 4, 2015

Six startups selected for tech-based accelerator program

For the second year, The Johns Hopkins University and Johns Hopkins Medicine are co-sponsoring an opportunity that prepares health information technology startups to present their innovative ideas to the world.

Released: March 3, 2015

Conflicting scores from respected national rating systems may confuse rather than guide consumers’ choices about where to seek quality care, say experts from the Johns Hopkins Armstrong Institute for Patient Safety and Quality.

Released: March 2, 2015

Mouse studies may lead to development of human therapies

Researchers at the Johns Hopkins University School of Medicine have now uncovered how a bacterial molecule controls the body’s response to TB infection and suggest that adjusting the level of this of this molecule may be a new way to treat the disease. The report appears this week as an advance online publication of Nature Medicine.

Released: March 2, 2015

New formula gauges 10-year risk of dying

Analyzing data from 58,000 heart stress tests, Johns Hopkins cardiologists report they have developed a formula that estimates one’s risk of dying over a decade based on a person’s ability to exercise on a treadmill at an increasing speed and incline.

Released: February 25, 2015

Findings are contrary to previous reports

Contrary to previous reports, a study led by Johns Hopkins researchers found that patients’ satisfaction scores only modestly improved based on the newly remodeled design of a hospital.

Released: February 25, 2015

Competition among doctors’ offices, urgent care centers and retail medical clinics in wealthy areas of the U.S. often leads to an increase in the number of antibiotic prescriptions written per person, a team led by Johns Hopkins researchers has found.

Released: February 23, 2015

Findings suggest high levels of false caregiver smoking reports, or second-hand exposure in multi-unit housing

Public health experts have long known that tobacco smoke exposure (TSE) can be harmful for children with bronchopulmonary dysplasia, a lung disease that often accompanies premature birth.

Released: February 23, 2015

Laboratory studies suggest anticancer drug already in clinical trials in children may interrupt this gene pathway.

Working with cells taken from children with a very rare but ferocious form of brain cancer, Johns Hopkins Kimmel Cancer Center scientists have identified a genetic pathway that acts as a master regulator of thousands of other genes and may spur cancer cell growth and resistance to anticancer treatment.

Released: February 20, 2015

Robert Ivkov, Ph.D., an assistant professor of radiation oncology and molecular radiation sciences at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center, has been awarded a three-year grant totaling $1,005,000 by the Jayne Koskinas Ted Giovanis Foundation for Health and Policy to develop nanoparticles — microscopic objects too tiny to see with the naked eye — that may help the body’s immune system recognize breast cancer cells. 
Released: February 20, 2015

First time there is data comparing effectiveness and safety of these drugs; Eylea found to outperform other drugs when vision loss is moderate to severe

A researcher from Johns Hopkins Medicine helped lead colleagues from across the country in a government-sponsored study by the Diabetic Retinopathy Clinical Research Network to discover that three drugs ? Eylea, Avastin and Lucentis ? used to treat diabetic macular edema are all effective. They also discovered that Eylea outperformed the other two drugs when vision loss was moderate to severe.

Released: February 19, 2015

Group dynamics, not star proteins, drive mechanics of crucial cell process

Like a surgeon separating conjoined twins, cells have to be careful to get everything just right when they divide in two. Otherwise, the resulting daughter cells could be hobbled, particularly if they end up with too many or two few chromosomes. Successful cell division hangs on the formation of a dip called a cleavage furrow, a process that has remained mysterious. Now, researchers at Johns Hopkins have found that no single molecular architect directs the cleavage furrow’s formation; rather, it is a robust structure made of a suite of team players.

Released: February 17, 2015

Four Web-based training modules developed by Johns Hopkins Medicine for emergency department personnel who treat patients with infectious diseases are now available on the Centers for Disease Control and Prevention (CDC)'s website.

Released: February 17, 2015

What is happening in the brain of an actor reciting Hamlet’s “to be or not to be” soliloquy or of the person next to you at lunch saying, “Please pass the salt”? For 150 years, scientists have known that a brain region called Broca’s area plays a key role in speech production, but exactly what it does and how it does it have been a mystery.

Released: February 16, 2015

Most “risk calculators” used by clinicians to gauge a patient’s chances of suffering a heart attack and guide treatment decisions appear to significantly overestimate the likelihood of a heart attack, according to results of a study by investigators at Johns Hopkins and other institutions.

Released: February 13, 2015

Mechanical stress is a key driver of cell-cell fusion, study finds

Just as human relationships are a two-way street, fusion between cells requires two active partners: one to send protrusions into its neighbor, and one to hold its ground and help complete the process.  Researchers have now found that one way the receiving cell plays its role is by having a key structural protein come running in response to pressure on the cell membrane, rather than waiting for chemical signals to tell it that it’s needed. The study, which helps open the curtain on a process relevant to muscle formation and regeneration, fertilization, and immune response, appears in the March 9 issue of the journal Developmental Cell.

Released: February 9, 2015

Venom’s toxins will be a powerful tool for studying epilepsy, schizophrenia and chronic pain

For more than a decade, a vial of rare snake venom refused to give up its secret formula for lethality; its toxins had no effect on the proteins that most venoms target. Finally, an international team of researchers figured out its recipe: a toxin that permanently activates a crucial type of nerve cell protein, preventing the cells from resetting and causing deadly seizures in prey.

Released: February 9, 2015

Both disorders involve faults in the same protein

Applying lessons learned from autism to brain cancer, researchers have discovered why elevated levels of the protein NHE9 add to the lethality of the most common and aggressive form of brain cancer, glioblastoma. Their discovery suggests that drugs designed to target NHE9 could help to successfully fight the deadly disease.

Released: February 6, 2015

Henry Brem, M.D., director of the Department of Neurosurgery at Johns Hopkins, has been selected to receive a Castle Connolly National Physician of the Year Award for Clinical Excellence.

Released: February 5, 2015

A new study by Johns Hopkins researchers links a well-known cell communication pathway called Notch to one of the most common — but overall still rare — brain tumors found in children.

Released: February 3, 2015

Despite improvements in the past few decades with surgery, chemotherapy and radiation therapy, a predictably curative treatment for glioma does not yet exist. New insights into specific gene mutations that arise in this often deadly form of brain cancer have pointed to the potential of gene therapy, but it’s very difficult to effectively deliver toxic or missing genes to cancer cells in the brain. Now, Johns Hopkins researchers report they have used nanoparticles to successfully deliver a new therapy to glioma cells in the brains of rats, prolonging their lives.

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.